IL142757A0 - Use of staurosporine derivatives for treating ocular neovascular diseases - Google Patents

Use of staurosporine derivatives for treating ocular neovascular diseases

Info

Publication number: IL142757A0
Authority: IL; Israel
Prior art keywords: treating ocular; ocular neovascular; neovascular diseases; staurosporine derivatives; treating
Prior art date: 1998-11-23

Application number

IL14275799A

Other languages

English (en)

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-11-23

Filing date

1999-11-22

Publication date

2002-03-10

1999-11-22 Application filed by Novartis Ag filed Critical Novartis Ag

2002-03-10 Publication of IL142757A0 publication Critical patent/IL142757A0/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Cardiology (AREA)
Ophthalmology & Optometry (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

IL14275799A 1998-11-23 1999-11-22 Use of staurosporine derivatives for treating ocular neovascular diseases IL142757A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US19867798A	1998-11-23	1998-11-23
PCT/EP1999/008987 WO2000030651A1 (en)	1998-11-23	1999-11-22	Use of staurosporine derivatives for treating ocular neovascular diseases

Publications (1)

Publication Number	Publication Date
IL142757A0 true IL142757A0 (en)	2002-03-10

Family

ID=22734344

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IL14275799A IL142757A0 (en)	1998-11-23	1999-11-22	Use of staurosporine derivatives for treating ocular neovascular diseases
IL142757A IL142757A (en)	1998-11-23	2001-04-23	Use in the history of staurosporine for the preparation of drugs for the treatment of diseases caused by the production of blood vessels in the eye

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IL142757A IL142757A (en)	1998-11-23	2001-04-23	Use in the history of staurosporine for the preparation of drugs for the treatment of diseases caused by the production of blood vessels in the eye

Country Status (19)

Country	Link
EP (1)	EP1131073B1 (pt)
JP (2)	JP2002530342A (pt)
KR (1)	KR100698449B1 (pt)
CN (1)	CN1172673C (pt)
AT (1)	ATE252387T1 (pt)
AU (1)	AU761092B2 (pt)
BR (1)	BR9915569A (pt)
CA (1)	CA2348890C (pt)
DE (1)	DE69912304T2 (pt)
DK (1)	DK1131073T3 (pt)
ES (1)	ES2211197T3 (pt)
HK (1)	HK1040182A1 (pt)
ID (1)	ID29970A (pt)
IL (2)	IL142757A0 (pt)
NO (1)	NO328085B1 (pt)
NZ (1)	NZ511559A (pt)
PT (1)	PT1131073E (pt)
WO (1)	WO2000030651A1 (pt)
ZA (1)	ZA200103925B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0122318D0 (en) *	2001-09-14	2001-11-07	Novartis Ag	Organic compounds
US20030119812A1 (en) *	2001-11-08	2003-06-26	Brazzell Romulus Kimbro	Method for decreasing capillary permeability in the retina
AU2003254566A1 (en) *	2002-07-23	2004-02-09	Novartis Ag	Ophtalmic ointment composition comprising a drug, an ointment base and a solubiling/dispersing agent
MX2007001155A (es) *	2004-07-29	2007-08-14	Creabilis Therapeutics Spa	Uso de inhibidores de k-252a y de quinasa para la prevencion o el tratamiento de patologias asociadas con hmgb1.
CN101580515B (zh) *	2008-05-16	2011-06-08	上海医药工业研究院	一种星形孢菌素提取纯化的方法
WO2010104933A1 (en)	2009-03-11	2010-09-16	Merck Sharp & Dohme Corp.	Inhibitors of akt activity
US8691825B2 (en)	2009-04-01	2014-04-08	Merck Sharp & Dohme Corp.	Inhibitors of AKT activity
CN102924479A (zh) *	2011-08-09	2013-02-13	山东鲁北药业有限公司	一种星孢菌素类衍生物的半合成方法
EP2755482B1 (en)	2011-09-15	2016-06-01	Merck Sharp & Dohme Corp.	Combination of mk-1775 and mk-8776 for treating cancer
DK2925888T3 (en)	2012-11-28	2017-12-18	Merck Sharp & Dohme	COMPOSITIONS AND METHODS OF CANCER TREATMENT

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL86632A0 (en) *	1987-06-15	1988-11-30	Ciba Geigy Ag	Derivatives substituted at methyl-amino nitrogen
US5093330A (en) *	1987-06-15	1992-03-03	Ciba-Geigy Corporation	Staurosporine derivatives substituted at methylamino nitrogen
WO1994001124A1 (en) *	1992-07-08	1994-01-20	Celtrix Pharmaceuticals, Inc.	METHOD OF TREATING OPHTHALMIC DISORDERS USING TGF-$g(b)
US6410322B1 (en) *	1993-07-27	2002-06-25	Hybridon Inc	Antisense oligonucleotide inhibition of vascular endothelial growth factor expression
WO1997034920A1 (en) *	1996-03-21	1997-09-25	Sugen, Inc.	Assays for kdr/flk-1 receptor tyrosine kinase inhibitors
UA54427C2 (uk) *	1996-05-01	2003-03-17	Елі Ліллі Енд Компані	Спосіб лікування очних захворювань, які пов'язані з фактором васкулярного ендотеліального росту
EP1806135A3 (en) *	1998-03-13	2010-11-24	The Johns Hopkins University School Of Medicine	The use of a protein tyrosine inhibitor such as genistein in the treatment of diabetic retinopathy or ocular inflammation

1999
- 1999-11-22 AT AT99957321T patent/ATE252387T1/de active
- 1999-11-22 KR KR1020017006415A patent/KR100698449B1/ko not_active IP Right Cessation
- 1999-11-22 DE DE69912304T patent/DE69912304T2/de not_active Expired - Lifetime
- 1999-11-22 EP EP99957321A patent/EP1131073B1/en not_active Expired - Lifetime
- 1999-11-22 ID IDW00200101090A patent/ID29970A/id unknown
- 1999-11-22 DK DK99957321T patent/DK1131073T3/da active
- 1999-11-22 IL IL14275799A patent/IL142757A0/xx active IP Right Grant
- 1999-11-22 JP JP2000583534A patent/JP2002530342A/ja not_active Ceased
- 1999-11-22 CA CA002348890A patent/CA2348890C/en not_active Expired - Fee Related
- 1999-11-22 NZ NZ511559A patent/NZ511559A/xx not_active IP Right Cessation
- 1999-11-22 BR BR9915569-9A patent/BR9915569A/pt not_active Application Discontinuation
- 1999-11-22 AU AU15066/00A patent/AU761092B2/en not_active Ceased
- 1999-11-22 WO PCT/EP1999/008987 patent/WO2000030651A1/en active IP Right Grant
- 1999-11-22 PT PT99957321T patent/PT1131073E/pt unknown
- 1999-11-22 ES ES99957321T patent/ES2211197T3/es not_active Expired - Lifetime
- 1999-11-22 CN CNB99813600XA patent/CN1172673C/zh not_active Expired - Fee Related
2001
- 2001-04-23 IL IL142757A patent/IL142757A/en not_active IP Right Cessation
- 2001-05-15 ZA ZA200103925A patent/ZA200103925B/en unknown
- 2001-05-21 NO NO20012490A patent/NO328085B1/no not_active IP Right Cessation
- 2001-12-31 HK HK01109238A patent/HK1040182A1/xx not_active IP Right Cessation
2011
- 2011-02-07 JP JP2011023933A patent/JP2011088938A/ja active Pending

Also Published As

Publication number	Publication date
NO20012490L (no)	2001-06-25
EP1131073A1 (en)	2001-09-12
CA2348890C (en)	2009-05-12
CA2348890A1 (en)	2000-06-02
ES2211197T3 (es)	2004-07-01
EP1131073B1 (en)	2003-10-22
PT1131073E (pt)	2004-03-31
JP2011088938A (ja)	2011-05-06
CN1328462A (zh)	2001-12-26
CN1172673C (zh)	2004-10-27
ID29970A (id)	2001-10-25
DE69912304T2 (de)	2004-07-22
DE69912304D1 (de)	2003-11-27
ZA200103925B (en)	2002-07-25
BR9915569A (pt)	2001-08-14
AU761092B2 (en)	2003-05-29
KR100698449B1 (ko)	2007-03-23
WO2000030651A1 (en)	2000-06-02
IL142757A (en)	2007-07-04
ATE252387T1 (de)	2003-11-15
KR20010078398A (ko)	2001-08-20
JP2002530342A (ja)	2002-09-17
DK1131073T3 (da)	2004-02-02
HK1040182A1 (en)	2002-05-31
NO328085B1 (no)	2009-11-30
AU1506600A (en)	2000-06-13
NZ511559A (en)	2004-01-30
NO20012490D0 (no)	2001-05-21

Publication	Publication Date	Title
AU3056702A (en)	2002-05-15	Methods and compositions for treatment of ocular neovascularization and neural injury
BR9811012A (pt)	2000-10-17	"uso de um composto".
AP2002002596A0 (en)	2002-09-30	Piperazine and piperidine derivatives.
WO1997002046A3 (de)	1997-07-03	Saccharid-konjugate
DE69834658D1 (de)	2006-06-29	Verwendung von aminothiolverbindungen zur behandlung von nerven- und nieren-erkrankungen und der arzneimitteltoxizität
DE69305776D1 (de)	1996-12-12	Behandlung neurodegenerativer Krankheiten
HK1029922A1 (en)	2001-04-20	Angiostatic agents and compositions for treating glc1a glaucoma
BR0210241A (pt)	2004-08-10	Piranoindazóis e seu uso no tratamento de glaucoma
DE69940951D1 (de)	2009-07-16	Nd wachstumshemmende mittel
CZ225995A3 (en)	1995-12-13	The use of riluzol for preparing medicament intended for treating neuronal degeneration caused by aids
HK1040182A1 (en)	2002-05-31	Use of staurosporine derivatives for treating ocular neovascular diseases
PL359027A1 (en)	2004-08-23	Improved treatment of neovascularization
EP1110554A4 (en)	2002-02-06	MEDICAL COMPOSITIONS FOR THE TREATMENT OF EYE DISEASES
HK1040184A1 (zh)	2002-05-31	治療青光眼之組合療法
ZA200201819B (en)	2003-05-28	Preventive and therapeutic agents for eye diseases.
WO2000009098A3 (en)	2000-05-18	Method for treating ocular neovascular diseases
EP1297849A4 (en)	2006-10-18	CURATIVE AGENT FOR OPTICAL AND SIMILAR NERVE DISEASES
GB9723780D0 (en)	1998-01-07	Regulation of ocular angiogenesis
EP1482922A4 (en)	2005-06-08	AGENTS FOR CORNEAL OR INTRASTROMAL ADMINISTRATION FOR TREATING OR PREVENTING OCULAR DISORDERS
WO2001002363A3 (en)	2001-07-05	N-substituted glycine derivatives
MX9604692A (es)	1998-04-30	Derivados de quinoxalina para el tratamiento de tinnitus.
BR0215752A (pt)	2005-03-29	Piranoindazóis e seu uso no tratamento de glaucoma
WO2000007582A3 (en)	2000-06-22	Use of thiazolidinedione derivatives for the treatment or prevention of cataracts
EP1570859A3 (en)	2008-04-02	Improved treatment of neovascularization
UA33498A (uk)	2001-02-15	Спосіб лікування терапевтично резистентних форм шизофренії

Legal Events

Date	Code	Title
2007-12-03	FF	Patent granted
2008-01-06	KB	Patent renewed
2010-05-17	KB	Patent renewed